Baker McKenzie has promoted Johanna Moesch to partner in its Zurich office, effective 1 July 2026, strengthening the firm's Data & Cyber, IT, Telecoms and Technology practice in Switzerland.
Tags :Baker McKenzie
Baker McKenzie has advised Pictet Alternative Advisors on the acquisition of the five-star Marriott Zurich hotel by the Elevation II Direct Real Estate Fund, in partnership with Vertell Asset Management as operating partner.
Baker McKenzie has advised Marvell Technology on its acquisition of Polariton Technologies, a Swiss-based developer of plasmonics-based silicon photonics devices, in a cross-border transaction spanning the US, Switzerland, and Belgium.
Centiel shares have been admitted to trading on the SIX Swiss Exchange following the completion of a reverse takeover. The transaction involved Centiel’s merger with HT5 AG, a company originating from the former Hochdorf
Baker McKenzie advised Acutronic Group in connection with a $25 million investment round led by InterAlpen Partners and Hale Capital Partners. The company Acutronic specalises in the development, design and manufacture of precision motion simulators for
Baker McKenzie Switzerland advised the Schulthess Group in connection with the refinancing of its syndicated senior term and multicurrency revolving credit facilities agreement. The transaction’s amount hasn’t been disclosed. The company Schulthess is
DBAG Fund VIII, a fund managed by Deutsche Beteiligungs (DBAG), acquired the Hipp Technology Group, a development partner and medical technology contract manufacturer, from an investor group represented by Endura. In connection with the deal,
Baker McKenzie advised Kulm Hotel, a luxury hotel located in St. Moritz, on a club deal financing. In connection with the deal, Advestra represented UBS Switzerland as coordinator, agent and lender, and Raiffeisen Switzerland as
Roche Holding, Roche Holdings, and Roche Finanz entered into a Swiss law governed USD 7.5 bn revolving credit facility agreement arranged by and syndicated among twelve international banks, coordinated by Deutsche Bank. In connection with the
Galderma, a Six-listed, pure-play dermatology category specialist, has entered into a USD 1 billion multicurrency revolving credit facility agreement. In connection with the deal, Advestra represented Galderma, while Baker McKenzie advised a syndicate consisting of twelve
